On June 7, 2022, the Federal Trade Commission (“FTC”) announced that it would launch an inquiry into the business practices of the nation’s six largest pharmacy benefit managers (“PBMs”). The inquiry will investigate the impact of vertically integrated PBMs on the access and affordability of prescription drugs. This news comes at a time when... READ MORE
FTC Launches Inquiry into Pharmacy Benefit Managers: Is This Time Different?
Posted on June 15, 2022 in Health Law News
Published by: Hall Render
